Owing to flexibility in shape, size, surface modifications, and composition, there is a large scope for the development of nanoparticles according to the needs of the drug delivery industry. Pharmaceutical applications of nanomaterials require a full understanding of the interaction of nanomaterials with biological systems. Many studies have proven that nanomaterials interact both actively and passively with the cellular environment. However, systematic studies showing these types of interactions and responses of cells toward nanomaterials are very rare. Cell-specific modifications, biological pathways, and biocompatibility are important parameters for designing innovative, specific drug-loaded nanomaterials. Systematic studies on the biointeraction and the properties of nanomaterials are of prime importance for the designing of suitable nanodevices.
|Title of host publication||Nano-Pharmacokinetics and Theranostics|
|Subtitle of host publication||Advancing Cancer Therapy|
|Number of pages||18|
|Publication status||Published - 01-01-2021|
All Science Journal Classification (ASJC) codes
- Economics, Econometrics and Finance(all)
- Business, Management and Accounting(all)